| U.S. Brand Names |
| Liqui-E® |
 |
| Generic Available |
|
No |
|
| Synonyms |
| TPGS |
|
| Pharmacological Index |
|
Vitamin, Fat Soluble |
|
| Use |
|
Treatment of vitamin E deficiency resulting from malabsorption due to prolonged cholestatic hepatobiliary disease |
|
| Pregnancy Risk Factor |
|
A/C |
|
| Usual Dosage |
|
Dietary supplement: Oral: 15 mg (400 units) every day |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Nursing Implications |
|
Studies indicate that TPGS is absorbed better than fat soluble forms of vitamin E in patients with impaired digestion and absorption and when coadministered with cyclosporin to transplant recipients it improves cyclosporin absorption. Due to these findings, this product has a valuable role in the liver transplant patient population. |
|
| Dosage Forms |
|
Liquid: 26.6 units/mL |
|
|
Copyright © 2007 Drugs Area |
